Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

Who should get the new RSV vaccines? Here's everything you need to know

There are now RSV vaccines approved for older adults and for pregnant people, and antibody shots (not vaccines) available for babies. What's the difference?

LiveScience

FDA approves RSV vaccine for moms-to-be to guard their newborns

U.S. regulators have approved the first RSV vaccine for pregnant women to protect their newborns

The Independent UK

Pfizer's RSV vaccine to protect babies gets greenlight from FDA

The Food and Drug Administration has approved the first vaccine for expectant mothers to shield their babies from RSV.

WEKU

From analysis to the latest developments in health,
read the most diverse news in one place.

Covid booster jabs could go on sale privately in UK in 2024

Health officials reiterate support for private provision as lower age limit for NHS booster vaccines raised to 65

The Guardian - UK

Management consultants can make great CEOs—but they have to get their hands dirty first

Some 47 Fortune 500 CEOs have spent time as management consultants but first took more junior roles.

Fortune

A tsunami of AI misinformation will shape next year’s knife-edge elections

If you thought social media had a hand in getting Trump elected, watch what happens when you throw AI into the mix

The Guardian - UK

Coronavirus FAQ: Is it wiser to get a booster now or wait for the new fall booster?

Maybe it's not a full-blown summer surge but COVID numbers are ticking up. For those with concerns due to personal risk factors or the start of the school year, the booster question is top of mind.

WEKU

Read news from The Economist, FT, and more,
with one subscription

‘Endless possibilities’: the chemists changing molecules atom by atom

A new method called ‘skeletal editing’ offers a hugely simplified way to alter matter, paving the way for world-changing innovations in personalised medicine and sustainable plastics

The Guardian - UK

Are Pfizer (PFE) and AbbVie (ABBV) Good Value Buys for August?

The pharma industry is poised to witness long-term growth with the introduction of generic medicines and growing demand for personalized and targeted treatments. Hence, fundamentally strong pharma stock AbbVie (ABBV) might be worth buying. However, it might not be the right time to invest in Pfizer (PFE). Keep reading.

StockNews.com

Babies should get new drug that prevents RSV, CDC panel says

A panel of U.S. health advisers is recommending that babies get a new drug to protect them against a respiratory virus

The Independent UK

The Most Objective Evidence Shows No Indication That Covid Vaccines Save More Lives Than They Take

Medical journals describe all-cause mortality in randomized controlled trials (RCTs)

Zenger

FDA Violated Own Safety And Efficacy Standards In Approving Covid-19 Vaccines For Children

Evidence the FDA used for those decisions violates at least three safety and efficacy standards from earlier FDA publications

Zenger

Tornado damage to Pfizer factory highlights vulnerabilities of drug supply

A tornado that ripped through a Pfizer plant in Rocky Mount, N.C., raised worries about shortages of medicines used in hospitals. The drugs include commonly used painkillers and anesthetics.

WEKU

3 Sectors, 3 Unusually Active Put Options to Sell

The markets have been on fire the past couple of weeks. While yesterday’s interest hike took some steam out of the markets, these three stocks and their options are unusually active and worthy of consideration.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Is the Rally Getting Long in the Tooth? Try These Bear Call Spread Trades

Traders should have a bearish outlook on the stock and ideally look to enter when the stock has a high implied volatility rank.

Fortune

Pfizer and Moderna parent are investing $100M to find the next big drug

"What we are doing now, I don’t think anyone has done so far," Pfizer CEO Albert Bourla says.

The Guardian - UK

Revealed: drug firms funding UK patient groups that lobby for NHS approval of medicines

Observer investigation shows that majority of Nice drug appraisals involve groups financially linked to maker of pharmaceuticals

The Independent UK

Tornado damage to Pfizer plant unlikely to cause major drug supply shortages, FDA says

A tornado that tore through eastern North Carolina and struck a large Pfizer pharmaceutical plant has damaged its drug storage facility but not its medicine production areas

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

Anti-vaxxers think God destroyed a Pfizer facility with a tornado

No vaccines were produced or stored at the facility

The Independent UK

Tornado damage to Pfizer plant will probably create long-term shortages of some drugs hospitals need

U.S. hospital drug supplies may be strained further after a tornado ripped open the roof of a Pfizer factory this week

Zenger

Large Tornado Hits North Carolina, Hospitalizes Several

Interstate 95 Shut Down as Pfizer Facility Suffers Damage

The Guardian - UK

Pascal Soriot of AstraZeneca: ‘The climate crisis is a health crisis’

The man who led the drive to create a not-for-profit Covid vaccine is now focusing on the deaths caused by global heating and pollution

The Independent UK

New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season

U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year

Zenger

Elderly Nursing Home Residents Denied Life-Saving COVID Treatment, Study Finds

Inadequate use of antiviral medication led to avoidable mortality, with Paxlovid underutilized

1 … 23 24 25 26

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.